Monitor Q3 2026 earnings for confirmation of the return to organic growth (at least +1%) and any further updates to the Value Creation Plan's financial targets. The unchanged Adjusted EBITDA and EPS guidance suggest limited near-term earnings upside, but the improved revenue trajectory and insider buying signal management confidence.
Price Chart
Executive Summary
Nomad Foods hosted an Analyst and Investor Day, raising its 2026 organic revenue outlook to a decline of 2%-3% (from prior 2%-5%) and guiding for a return to organic growth in Q3 2026. Management introduced a multi-year Value Creation Plan targeting sustainable revenue and earnings growth, while maintaining unchanged Adjusted EBITDA, Adjusted EPS, and Free Cash Flow guidance. The stock is likely to react positively to the improved revenue trajectory and insider buying of ~$10.5M over 13 months, but the EPS miss vs consensus and continued organic revenue decline for the full year temper the bullish case.
Key Financial Metrics
Key Facts
- Q2 2026 EPS of $0.40 missed consensus of $0.45 by 11.7%
- Q2 2026 revenue of $739.3M matched consensus
- Full-year 2026 organic revenue guidance improved to a decline of 2%-3% (from prior 2%-5%)
- Q3 2026 organic revenue growth expected to be at least +1%, marking a return to growth
- Adjusted EBITDA guidance unchanged: decline of 5%-10% (including up to mid-single-digit headwind from restoring incentive compensation)
- Adjusted EPS guidance unchanged at €1.38-€1.53
- Adjusted Free Cash Flow conversion guidance unchanged at 90% or greater
- Management and leadership team purchased ~$10.5M of NOMD shares in the open market over the past 13 months
- Multi-year Value Creation Plan introduced targeting sustainable revenue and earnings growth
- Productivity initiatives expected to exceed the previously announced €200 million target
Financial Impact
Improved organic revenue outlook by ~2pp at the midpoint (from -3.5% to -2.5% decline); EPS guidance unchanged at €1.38-€1.53; insider buying of ~$10.5M
Risk Factors
- Q2 2026 EPS miss of 11.7% vs consensus indicates ongoing earnings pressure
- Full-year organic revenue still expected to decline 2%-3%, reflecting continued headwinds
- Adjusted EBITDA guidance of -5% to -10% implies margin compression even as revenue improves
- Execution risk on the multi-year Value Creation Plan and productivity targets
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-prn-302899199 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 6, 2026 20d ago | 6-K | $10.97 | awaiting T+60 | — | $11.86 (+8.11%) |
Oct 6, 2026 20d ago | Press Release | $10.97 | awaiting T+60 | — | $11.86 (+8.11%) |
Aug 26, 2026 8w ago | Insider Cluster | $11.99 | awaiting T+60 | — | $11.86 (−1.08%) |
Aug 13, 2026 10w ago | Press Release | $12.04 | awaiting T+60 | — | $11.86 (−1.50%) |
Jul 30, 2026 12w ago | 6-K | $12.41 $12.00 | ▼ −3.30% | ▼ −5.77% | $11.86 (−4.43%) |
Jul 22, 2026 13w ago | 6-K | $11.65 $11.49 | ▼ −1.37% | ▼ −5.93% | $11.86 (+1.80%) |
Jul 20, 2026 14w ago | 6-K | $11.85 $11.47 | ▲ +3.21% | ▲ +8.05% | $11.86 (−0.08%) |
Jul 20, 2026 14w ago | Press Release | $11.85 $11.47 | ▲ +3.21% | ▲ +8.05% | $11.86 (−0.08%) |
Jun 24, 2026 17w ago | 6-K | $10.65 $10.74 | ▲ +0.85% | ▼ −1.99% | $11.86 (+11.36%) |
Jun 8, 2026 19w ago | 6-K | $10.23 $11.59 | ▲ +13.29% | ▲ +9.48% | $11.86 (+15.93%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers